Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124403 | SCV000167836 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000124403 | SCV000302024 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Center for Human Genetics, |
RCV000659419 | SCV000781232 | likely benign | Ehlers-Danlos syndrome, type 4 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001811204 | SCV001472589 | benign | not provided | 2023-09-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000659419 | SCV002373364 | benign | Ehlers-Danlos syndrome, type 4 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496447 | SCV002804271 | benign | Ehlers-Danlos syndrome, type 4; Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome | 2022-03-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029619 | SCV000052271 | benign | Familial aortopathy | 2015-06-04 | no assertion criteria provided | clinical testing |